Evaluating breath methane as a diagnostic test for constipation-predominant IBS. (Q46084685)

19 December 2017

title

Evaluating breath methane as a diagnostic test for constipation-predominant IBS. (English)

1 reference

19 December 2017

1 reference

1 reference

8

Mark Pimentel

1 reference

19 December 2017

Laura Hwang

1

1 reference

19 December 2017

Kimberly Low

2

1 reference

19 December 2017

Reza Khoshini

3

1 reference

19 December 2017

Gil Melmed

4

1 reference

19 December 2017

Ara Sahakian

5

1 reference

19 December 2017

Marc Makhani

6

1 reference

19 December 2017

Venkata Pokkunuri

7

1 reference

19 December 2017

publication date

18 March 2009

1 reference

19 December 2017

Digestive Diseases and Sciences

published in

1 reference

19 December 2017

volume

55

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

398-403

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-009-0778-4

exact match

0 references

cites work

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0778-4

The degree of breath methane production in IBS correlates with the severity of constipation

21 January 2018

1 reference

12 December 2020

Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.

1 reference

12 December 2020

Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders

1 reference

12 December 2020

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

1 reference

12 December 2020

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

1 reference

12 December 2020

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

12 December 2020

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

1 reference

12 December 2020

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

1 reference

12 December 2020

Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

12 December 2020

Functional bowel disorders and functional abdominal pain

1 reference

12 December 2020

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

1 reference

12 December 2020

Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life.

1 reference

12 December 2020

Prevalence of irritable bowel syndrome: a community survey

1 reference

12 December 2020

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

12 December 2020

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

1 reference

12 December 2020

Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls

1 reference

12 December 2020

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

1 reference

12 December 2020

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

1 reference

12 December 2020

Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study

1 reference

12 December 2020

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

12 December 2020

10.1007/S10620-009-0778-4

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19294509

1 reference

19 December 2017